홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.0
  1. 홈
  2. /반응

Lithium borohydride → Ether isohexane

HRID 1024975
노트
인쇄 미리보기

반응식

HRID 1024975 반응식
[F:1][C:2]1[C:34]([F:35])=[CH:33][CH:32]=[CH:31][C:3]=1[CH2:4][S:5][C:6]1[N:11]=[C:10]([O:12][C@H:13]([CH3:19])[C:14](OCC)=[O:15])[CH:9]=[C:8]([NH:20][S:21]([C:24]2[N:25]=[C:26]([CH3:30])[N:27]([CH3:29])[CH:28]=2)(=[O:23])=[O:22])[N:7]=1.[BH4-].[Li+]>C1COCC1>[CH3:9][CH2:10][O:12][CH2:13][CH3:14].[CH3:33][CH2:34][CH2:2][CH:3]([CH3:31])[CH3:4].[F:1][C:2]1[C:34]([F:35])=[CH:33][CH:32]=[CH:31][C:3]=1[CH2:4][S:5][C:6]1[N:7]=[C:8]([NH:20][S:21]([C:24]2[N:25]=[C:26]([CH3:30])[N:27]([CH3:29])[CH:28]=2)(=[O:23])=[O:22])[CH:9]=[C:10]([O:12][C@H:13]([CH3:19])[CH2:14][OH:15])[N:11]=1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

5

반응물 2

HCID 4148881Lithium borohydrideHCID 53628392HCID 53628392, 화합물

생성물 2

HCID 21882825Ether isohexaneHCID 59558844N-{2-[(2,3-Difluorobenzyl)thio]-6-[(1R)-2-hydroxy-1-methylethoxy]pyrimidin-4-yl}-1,2-dimethyl-1H-imidazole-4-sulfonamide

시약·촉매·용매 1

HCID 8028Tetrahydrofuran용매

실험 절차

The title compound was prepared according to the procedure outlined in example 11 using a mixture of ethyl (2R)-2-[(2-[(2,3-difluorobenzyl)thio]-6-{[(1,2-dimethyl-1H-imidazol-4-yl)sulfonyl]amino}pyrimidin-4-yl)oxy]propanoate (the product from step (i) (0.25 g), lithium borohydride (2M solution in THF, 0.48 mL) and THF (6 mL). Purification was by reverse phase HPLC (symmetry as the stationary phase and TFA/acetonitrile as the mobile phase) then titurated with Toluene, DCM and then Et2O/iso-hexane to give the title compound as a white solid, 44 mg

후처리

  1. customThe title compound was prepared
  2. customPurification

출처 및 근거

ORD 기록
ord-8e74db7cff8d45a6ab0499e086438030
출처 데이터셋
uspto-grants-2014_05
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08722883B2

반응 노트

불러오는 중…

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트